Literature DB >> 11559025

Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.

H Chen1, J Liu, C Q Zhao, B A Diwan, B A Merrick, M P Waalkes.   

Abstract

Numerous studies link arsenic exposure to human cancers in a variety of tissues, including the liver. However, inorganic arsenic has never been unequivocally shown to be an animal carcinogen, and its carcinogenic mechanism remains undefined. Our previous studies indicate that chronic (> or =18 weeks), low-level (125 to 500 nM) exposure to arsenite induces malignant transformation in the normally nontumorigenic rat liver epithelial cell line (TRL 1215), and these chronic arsenic-exposed (CAsE) cells produce invasive and metastatic tumors upon inoculation into nude mice. In addition, a prior microarray screening analysis of aberrant gene expression showed several oncogenes were overexpressed in CAsE cells exposed to 500 nM arsenite, including a prominent overexpression of the protooncogene c-myc, as well as genes related to cell proliferation. Thus, to better understand the mechanism of arsenic carcinogenesis, we studied the role of c-myc overexpression in arsenite-induced cell transformation. The upregulation of c-myc was confirmed by RT-PCR at the transcription level and by Western blot analysis for the translation product. Further analysis showed that arsenite produced significant increases in the steady-state expression of c-myc in a time- and concentration-dependent manner during the malignant transformation process. The level of c-myc expression was highly correlated (r = 0.988) with tumor formation after inoculation of CAsE cells into nude mice and was also highly correlated (r = 0.997) with genomic DNA hypomethylation. CAsE cells showed a high cell proliferation rate in a fashion related to the level of arsenic exposure. The expression of c-myc was highly correlated with cellular hyperproliferation (r = 0.961). Consistent with the enhanced proliferation both proliferating cell nuclear antigen and cyclin D1 were overexpressed in CAsE cells. In summary, a prominent overexpression of c-myc, a gene frequently activated during hepatocarcinogenesis, is strongly correlated with several events possibly associated with arsenic-induced malignant transformation, including hyperproliferation, DNA hypomethylation and tumor formation upon inoculation into nude mice. These correlations provide convincing evidence c-myc overexpression is mechanistically important in arsenic-induced malignant transformation in this model system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11559025     DOI: 10.1006/taap.2001.9253

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  35 in total

1.  Aberrant cell proliferation by enhanced mitochondrial biogenesis via mtTFA in arsenical skin cancers.

Authors:  Chih-Hung Lee; Shi-Bei Wu; Chien-Hui Hong; Wei-Ting Liao; Ching-Ying Wu; Gwo-Shing Chen; Yau-Huei Wei; Hsin-Su Yu
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Environmental chemical exposures and human epigenetics.

Authors:  Lifang Hou; Xiao Zhang; Dong Wang; Andrea Baccarelli
Journal:  Int J Epidemiol       Date:  2011-12-13       Impact factor: 7.196

3.  Low-level arsenic causes proteotoxic stress and not oxidative stress.

Authors:  Matthew Dodson; Montserrat Rojo de la Vega; Bryan Harder; Raul Castro-Portuguez; Silvia D Rodrigues; Pak Kin Wong; Eli Chapman; Donna D Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2018-02-03       Impact factor: 4.219

Review 4.  Molecular Mechanisms of Arsenic-Induced Disruption of DNA Repair.

Authors:  Lok Ming Tam; Nathan E Price; Yinsheng Wang
Journal:  Chem Res Toxicol       Date:  2020-02-07       Impact factor: 3.739

Review 5.  Epigenetics and environmental chemicals.

Authors:  Andrea Baccarelli; Valentina Bollati
Journal:  Curr Opin Pediatr       Date:  2009-04       Impact factor: 2.856

6.  Enhanced glutathione biosynthetic capacity promotes resistance to As3+-induced apoptosis.

Authors:  James A Thompson; Christopher C Franklin
Journal:  Toxicol Lett       Date:  2009-12-16       Impact factor: 4.372

Review 7.  Liver is a target of arsenic carcinogenesis.

Authors:  Jie Liu; Michael P Waalkes
Journal:  Toxicol Sci       Date:  2008-06-19       Impact factor: 4.849

8.  Toxicokinetic and genomic analysis of chronic arsenic exposure in multidrug-resistance mdr1a/1b(-/-) double knockout mice.

Authors:  Yaxiong Xie; Jie Liu; Yaping Liu; Curtis D Klaassen; Michael P Waalkes
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

9.  Arsenic and the epigenome: interindividual differences in arsenic metabolism related to distinct patterns of DNA methylation.

Authors:  Kathryn A Bailey; Michael C Wu; William O Ward; Lisa Smeester; Julia E Rager; Gonzalo García-Vargas; Luz-Maria Del Razo; Zuzana Drobná; Miroslav Stýblo; Rebecca C Fry
Journal:  J Biochem Mol Toxicol       Date:  2013-01-11       Impact factor: 3.642

10.  Assessment of the effect of betaine on p16 and c-myc DNA methylation and mRNA expression in a chemical induced rat liver cancer model.

Authors:  Yan-ping Du; Jun-sheng Peng; Ai Sun; Zhi-hong Tang; Wen-hua Ling; Hui-lian Zhu
Journal:  BMC Cancer       Date:  2009-07-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.